Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amedeo Lonardo

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
World Journal of Gastroenterology|July 10, 2024
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!Amedeo Lonardo
Expert Review of Clinical Pharmacology|September 18, 2023
The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiersAmedeo Lonardo
Journal of Clinical Medicine|February 12, 2021
Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?Amedeo Lonardo
Medical Sciences (Basel, Switzerland)|November 24, 2025
Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver DisordersRalf Weiskirchen, Amedeo Lonardo
International Journal of Molecular Sciences|July 12, 2025
The Ovary-Liver Axis: Molecular Science and EpidemiologyRalf Weiskirchen, Amedeo Lonardo
British Journal of Pharmacology|February 13, 2025
How 'miracle' weight-loss semaglutide promises to change medicine but can we afford the expense?Ralf Weiskirchen, Amedeo Lonardo
Metabolites|August 28, 2024
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via MetabolomicsAmedeo Lonardo, Ralf Weiskirchen
Open Medicine (Warsaw, Poland)|April 13, 2026
Mitochondrial medicine in obesity: a scoping reviewAmedeo Lonardo, Ralf Weiskirchen
Journal of Clinical Medicine|May 2, 2020
Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational ResearchAmedeo Lonardo, Ayako Suzuki
Expert Opinion on Therapeutic Targets|May 8, 2026
Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver diseaseRalf Weiskirchen, Amedeo Lonardo
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
World Journal of Gastroenterology|July 10, 2024
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!Amedeo Lonardo
Expert Review of Clinical Pharmacology|September 18, 2023
The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiersAmedeo Lonardo
Journal of Clinical Medicine|February 12, 2021
Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?Amedeo Lonardo
Medical Sciences (Basel, Switzerland)|November 24, 2025
Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver DisordersRalf Weiskirchen, Amedeo Lonardo
International Journal of Molecular Sciences|July 12, 2025
The Ovary-Liver Axis: Molecular Science and EpidemiologyRalf Weiskirchen, Amedeo Lonardo
British Journal of Pharmacology|February 13, 2025
How 'miracle' weight-loss semaglutide promises to change medicine but can we afford the expense?Ralf Weiskirchen, Amedeo Lonardo
Metabolites|August 28, 2024
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via MetabolomicsAmedeo Lonardo, Ralf Weiskirchen
Open Medicine (Warsaw, Poland)|April 13, 2026
Mitochondrial medicine in obesity: a scoping reviewAmedeo Lonardo, Ralf Weiskirchen
Journal of Clinical Medicine|May 2, 2020
Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational ResearchAmedeo Lonardo, Ayako Suzuki
Expert Opinion on Therapeutic Targets|May 8, 2026
Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver diseaseRalf Weiskirchen, Amedeo Lonardo
Pageof 14